Journal of Hepatocellular Carcinoma

ISSN: 2253-5969

Journal Articles:

Immune Checkpoint Inhibitors (PD-1/PD-L1) in Hepatocellular Carcinoma Treatment (2)
Addressing Global Differences in HCC Risk Factors and Management Strategies (2)
Advanced Radiation Therapy and Radiobiology for Hepatocellular Carcinoma (7)
Insights and Innovations in Imaging for Hepatocellular Carcinoma: Advancing Diagnosis and Management (6)
The Emerging Multiple Modality Treatment Based on Systemic Therapy for Hepatocellular Carcinoma (HCC) (11)
Combination of Immune Checkpoint Inhibitors and Locoregional Therapy of Hepatocellular Carcinoma: Hype or Hope (1)

Immune Checkpoint Inhibitors (PD-1/PD-L1) in Hepatocellular Carcinoma Treatment

Immune checkpoint inhibitors targeting PD-1 and PD-L1 have significantly impacted the treatment landscape for HCC. By blocking the signals that prevent T-cells from attacking cancer cells, these inhibitors enhance the immune system's ability to combat tumors. These therapies have shown potential in improving survival rates, reducing tumor burden, and providing durable responses in patients who previously had few effective options.

Original Research

Liver Transplantation After Radiotherapy-Antiangiogenesis-Immune Checkpoint Blockade Combination Therapy in Hepatocellular Carcinoma with Major Portal Vein Tumor Thrombosis: A Propensity Score Matching Analysis

Zhao Y, Song J, Li K, Li T, Li W, Yang Y, Tong X, Xiao Y, Xu G, Lu Q, Li G, Li G, Dong J

Journal of Hepatocellular Carcinoma 2026, 13:570163

Published Date: 8 May 2026

Original Research

Immunotherapy-Based Strategies versus Transcatheter Arterial Chemoembolization and the Impact of Treatment Duration in Hepatocellular Carcinoma with Microvascular Invasion: A Retrospective Multicenter Cohort Study

Chen X, Xing J, Zhang B, Peng W, Huang Z, Zhu T, Liu L, Liu X, Wan X, Mao Y, Chang X, Zhou K, Pan J, Hu D, Tan H, Zhang Y, Guan M, Du S

Journal of Hepatocellular Carcinoma 2025, 12:2379-2391

Published Date: 21 October 2025